Pharmaceutical Waste Disposal and Compliance Flashcards

Under EPA and RCRA regulations, what distinguishes 'trace chemotherapy waste' from 'bulk chemotherapy waste'?

Answer: Trace waste is defined as containers, tubing, and PPE with residual amounts (typically ≤3% by weight); bulk waste contains more than a trace amount of chemotherapy drug

Trace chemotherapy waste (also called RCRA 'empty' containers) includes items with residual drug such as IV bags, tubing, gloves, and gowns after use. Bulk chemotherapy waste contains a significant amount of drug and is classified as P-listed or U-listed RCRA hazardous waste, requiring more stringent disposal. The distinction matters because disposal requirements and costs differ significantly.

Which regulatory body primarily governs the disposal of hazardous pharmaceutical waste (including chemotherapy drugs) in the United States?

Answer: The Environmental Protection Agency (EPA) under RCRA

The EPA regulates hazardous waste disposal under the Resource Conservation and Recovery Act (RCRA). Many chemotherapy drugs are classified as RCRA hazardous waste (P-listed or U-listed). States may have additional or more stringent regulations, but EPA/RCRA is the federal framework governing hazardous pharmaceutical waste disposal.

A compounding technician has finished preparing a hazardous drug IV admixture. The used IV bag, tubing set, and gloves are considered trace chemotherapy waste. How should this waste be disposed of?

Answer: In a properly labeled chemotherapy (black or yellow) waste container designated for trace chemo waste, segregated from regular trash and biohazardous waste

Trace chemotherapy waste must be placed in appropriately labeled, closeable chemo waste containers (often yellow or black with chemotherapy labels) and segregated from regular trash and infectious waste. Flushing to drain or placing in standard trash is prohibited and constitutes an environmental violation under RCRA.

Which of the following hazardous drugs is classified as a DEA Schedule II controlled substance AND requires compliance with both DEA disposal regulations AND hazardous drug handling guidelines?

Answer: Morphine for injection (compounded)

Morphine is a DEA Schedule II controlled substance. When compounded as a sterile preparation, it must comply with DEA regulations for controlled substance disposal (e.g., witnessed waste, destruction logs) AND any applicable hazardous drug handling protocols if classified as hazardous. Methotrexate and cyclophosphamide are hazardous drugs but are not controlled substances.

Spent sharps (needles, syringes) used during sterile compounding of hazardous drugs must be disposed of in what manner?

Answer: In a puncture-resistant sharps container that is also appropriate for chemotherapy-contaminated sharps, then disposed of as chemotherapy waste

Sharps contaminated with hazardous drugs must be placed in a puncture-resistant sharps container that is also labeled and designated for chemotherapy waste. They cannot be disposed of in standard (red) infectious waste sharps containers because of the chemical hazard. Needle clipping is prohibited under OSHA bloodborne pathogen standards.

A vial of methotrexate is dropped and broken in the sterile compounding area. In addition to cleaning up the spill using a hazardous drug spill kit, what must occur regarding the waste generated from the cleanup?

Answer: All spill cleanup materials (absorbent pads, PPE, broken glass) must be placed in a sealed, labeled hazardous drug waste container and disposed of as chemotherapy waste

All materials used to clean up a hazardous drug spill — including absorbent pads, PPE (gown, gloves, mask), and any broken container pieces — are contaminated with hazardous drug and must be treated as hazardous waste. They must be sealed in a properly labeled chemotherapy waste container. Regular biohazard or trash disposal is a regulatory violation.